Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Aug 7, 2026
16 days ago · 100% complete
NOT DEPENDABLE This report predates a filing — its financial basis has been replaced.
Report generated: Aug 7, 2026 · Filing on record since: Aug 19, 2026 · 12 days after
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Capital One Financial Corporation (COF) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-23): Designation Low · Gem Score -34 (−100…+100 Quality+Value blend) · Quality 5 · Value -66 · Sentiment 35 (timing only, not weighted) · Composite fair value $284.62 vs $220.00 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Capital One Financial Corporation

COF NYSE
Financial Services · Credit Services
McLean, VA 22102, United States capitalone.com Updated Aug 6, 3:32am
Price
$221.63
Market Cap
$136.0B
Employees
78,400
Beta
1.02
Avg Volume
4,309,632
Last Dividend
$3.00
CEO
Mr. Richard D. Fairbank

Capital One Financial Corporation is a diversified financial services holding company headquartered in McLean, Virginia. The company operates primarily through three business segments: credit card, consumer banking, and commercial banking. In its credit card segment, Capital One provides a broad range of branded and co-branded credit card products to consumers and small businesses, serving both prime and subprime customer segments. Its consumer banking operations offer checking and savings accounts, money market deposits, certificates of deposit, auto loans, and other retail lending products, delivered through digital platforms, physical branches, and café-style locations in selected U.S. markets. The commercial banking segment focuses on lending, treasury management, deposit services, and capital markets solutions for mid-sized and large corporate clients, as well as real estate and industrial borrowers. Capital One Financial Corporation serves customers across the United States, Canada, and the United Kingdom, with a strong emphasis on digital banking and data-driven risk management. Founded in 1988, it is recognized today as a major player in consumer credit and broader retail and commercial banking services.

Runs with full report Generated: Aug 7, 2026 12:20am
Price Overview
Price at report time
$220.00
as of Aug 7, 12:20am (16d ago)
Change · Aug 7
-1.63 (-0.74%)
Day Range
$219.32 – $222.32
52-Week Range
$174.24 – $259.64
50-Day MA
$199.72
200-Day MA
$207.59
Volume
1,928,493.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 16d).
Share Structure
Outstanding 613,484,836.00
Float 600,712,082.00
Free Float 97.9%
High free float — 97.9% of shares trade freely, ~2.1% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 7, 2026 12:34am (16d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Aug 5, 2026 9:35am (18d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Aug 7, 2026 12:18am
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
54.59
Stock Price: $221.63
EPS (Diluted): 4.03
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
1.18
Stock Price: $221.63
Total Equity: $113.62B
Shares: 608,684,864
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
Market Cap: $135.97B
Total Debt: $1.09B
Cash: $62.09B
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$57.9B
Market Cap: $135.97B
Total Debt: $1.09B
Cash: $62.09B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
Gross Profit: N/A
Revenue: $53.43B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
Operating Income: N/A
Revenue: $53.43B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
4.6%
Net Income: $2.45B
Revenue: $53.43B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
2.2%
Net Income: $2.45B
Total Equity: $113.62B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
Operating Income: N/A
Tax Rate: 8.5%
Equity: $113.62B
Total Debt: $1.09B
Cash: $62.09B
Missing from API: Operating Income
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
Current Assets: N/A
Current Liabilities: N/A
Missing from API: Current Assets, Current Liabilities
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.01
Short-Term Debt: $1.09B
Long-Term Debt: $0.00
Total Debt: $1.09B
Total Equity: $113.62B
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$87.79
Revenue: $53.43B
Shares: 608,684,864
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$186.66
Total Equity: $113.62B
Shares: 608,684,864
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$42.95
Operating CF: $27.72B
CapEx: -$1.58B
Shares: 608,684,864
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
1.4%
Last Dividend: $3.00
Stock Price: $221.63
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
61.8%
Dividends Paid: -$1.52B
Net Income: $2.45B
Industry Benchmarks
Last run: Aug 7, 2026 12:17am
Compares COF against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Aug 5, 2026 9:35am (18d ago)
Metric 2021 2022 2023 2024 2025
Revenue $30.4B $34.3B $36.8B $39.1B $53.4B
Cost of Revenue
Gross Profit
Operating Expenses $10.3B $12.4B $13.3B $14.0B $18.4B
Operating Income
Net Income $12.4B $7.4B $4.9B $4.8B $2.5B
EBITDA
EPS $27.04 $17.98 $11.98 $11.61 $4.03
EPS (Diluted) $26.94 $17.91 $11.95 $11.59 $4.03
Balance Sheet (Annual)
Last updated: Aug 5, 2026 9:35am (18d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $22.1B $31.3B $43.8B $43.7B $62.1B
Total Current Assets
Total Assets $432.4B $455.2B $478.5B $490.1B $669.0B
Current Liabilities
Long-Term Debt
Total Liabilities $371.4B $402.7B $420.4B $429.4B $555.4B
Total Equity $61.0B $52.6B $58.1B $60.8B $113.6B
Retained Earnings $51.0B $57.2B $60.9B $64.5B $65.2B
Cash Flow (Annual)
Last updated: Aug 7, 2026 12:34am (16d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $12.3B $13.8B $20.6B $18.2B $27.7B
Capital Expenditure -$698.0M -$934.0M -$961.0M -$1.2B -$1.6B
Free Cash Flow $11.6B $12.9B $19.6B $17.0B $26.1B
Acquisitions (net) -$669.0M -$1.2B -$2.8B $0 $16.5B
Net Debt Issued / (Repaid)
Dividends Paid -$1.1B -$950.0M -$931.0M -$932.0M -$1.5B
Stock Buybacks -$7.6B -$4.9B -$718.0M -$734.0M -$4.1B
Net Change in Cash -$18.7B $9.2B $12.5B -$84.0M $18.4B
Growth Trends (YoY %)
Last updated: Aug 5, 2026 9:35am (18d ago)
Metric 2022 2023 2024 2025
Revenue Growth +12.5% +7.4% +6.3% +36.6%
Gross Profit Growth
Operating Income Growth
Net Income Growth -40.6% -33.6% -2.8% -48.4%
EBITDA Growth
Dividend History (Last 20)
Last updated: Aug 5, 2026 9:35am (18d ago)
Date Dividend Declaration Record Payment
2026-05-19 $0.80
2026-02-19 $0.80
2025-11-17 $0.80
2025-08-15 $0.60
2025-05-23 $0.60
2025-02-18 $0.60
2024-11-14 $0.60
2024-08-12 $0.60
2024-05-10 $0.60
2024-02-09 $0.60
2023-11-10 $0.60
2023-08-04 $0.60
2023-05-12 $0.60
2023-02-03 $0.60
2022-11-10 $0.60
2022-08-05 $0.60
2022-05-13 $0.60
2022-02-11 $0.60
2021-11-12 $0.60
2021-08-06 $0.60
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 17 computed · 6 not applicable · 1 not yet run
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 08:44
5.6 : 1 recovery upside vs repeat-quarter downside
Recovery pays +223%; another quarter like the worst recent one costs 39%. Ratio 5.6:1. Caveat: revenue-DCF fits financials poorly (reported revenue omits net interest) — treat the legs as rough.
CaseGrowthMarginFair valuevs price ($220.00)
Bull — recovery +53% 17.3% $709.73 +223%
Base — stabilizes +36% 15.0% $387.21 +76%
Bear — keeps slipping +18% 12.8% $197.61 -10%
Stress — last quarter repeats +31% 5.5% $133.20 -39%
The next quarters keep the trajectory of the worst recent matched quarter (ending 2025-06-30) — growth stays at 31.4% and margins bend by the same profit-vs-revenue ratio (×1.00). Stress is a trajectory, not a prediction — it answers "what if the ship's current heading simply continues," which history says is the case to respect.
Why this is appearing: this company files quarterly, so its recent trajectory could be measured rather than assumed — the engine matched Mar 2026 against the same quarter one year earlier and found revenue +52.3% · net income +54.8% year-over-year. That measured heading is what the stress case extends forward. Of those, the stress case extends the worst matched quarter — the one ending Jun 30, 2025 (revenue +31.4% YoY) — not the average. Data measured through Mar 31, 2026 — this card recalculates automatically when the next quarterly filing is ingested. Companies without quarterly filings (many foreign listings) never show this card: with no measured trajectory, there is nothing honest to repeat.
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for COF — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-08-07 00:33:36
Verdict Fairly valued to modestly rich near $221; synthesis fair value of $147 is wrong because it anchors on merger-distorted GAAP earnings — normalized fair value is $180-210, accumulate below $195.

The raw numbers tell a story the models are partially misreading. The revenue step-function from ~$10B/quarter through Q1 2025 to $12.5B in Q2 and $15.2-15.6B thereafter isn't organic growth — that's the Discover close (completed May 2025), and it makes every YoY and CAGR figure in the momentum block nonsense. The 20.5% "revenue CAGR" is a merger artifact. So is the -$4.28B Q2 2025 loss, which is almost certainly CECL Day 2 provisioning on the acquired Discover book plus deal costs. Strip that out and Q3-Q1 2026 run-rate NI is ~$2.5B/quarter or ~$10B annualized, putting normalized EPS closer to $15-16 and forward P/E around 14x — not the 54x headline. The pre-flight AI and thesis eval both nod at this ($15 normalized EPS, 13-14x), but the valuation synthesis anchoring on $159 fair value and the market-forces "catastrophic credit losses" thesis appear to be pricing off trailing GAAP earnings that include the merger charge. That's a material error.

The balance sheet reinforces this. $113.6B of equity against a $136B market cap is 1.18x P/B — for a bank that just absorbed Discover's payment network (an actual moat, not a story) and is generating $26B FCF, this is not a stretched multiple. Compare to JPM at ~2.3x, BAC ~1.3x. If Capital One earns even a 10% ROE on $114B equity, that's $11.4B in earnings, or 12x forward. The market-forces model calling COF a "deteriorating subprime lender" reads like a stale 2008-era template — COF's subprime card mix has been declining for a decade, and Discover's prime revolver book actually improves the credit mix. The bear case that "unemployment at 4.1% is the bottom" is legitimate cyclical risk, but it's a macro call, not a company-specific indictment.

Where I'd push back on the bulls: the insider activity is uniformly selling — nine sales versus one award grant over three months. Small share counts, but zero open-market buying at $221 tells you insiders don't see obvious upside from here. The 2.2% ROE and 0.37% ROA on TTM basis are genuinely ugly and won't normalize instantly — CECL provisioning on Discover will bleed into 2026 prints, and merger integration typically takes 24-36 months to hit synergy targets. The $2-3B Discover synergy number in the thesis eval is management's number; historical bank M&A delivers ~60-70% of promised synergies. Also, the dividend payout ratio of 61.8% on depressed earnings is misleading — the actual dividend cost is manageable, but the ratio optically constrains buyback capacity while integration completes. And the "$62B cash" line is deceptive for a bank; that's regulatory liquidity, not deployable capital.

Net: I dissent from the synthesis "overvalued at $147 fair value." That number is built on merger-distorted trailing earnings and treats a one-time CECL charge as run-rate. The narrative layer's 60/40 story-to-fundamentals split also overstates the story component — the Discover network is a hard asset with real economics, not a vibe. My read: on normalized ~$15 EPS and a 12-14x multiple appropriate for a diversified card+bank at mid-cycle credit, fair value is $180-210. Current $221 is modestly full but not egregious, and the setup into 2026-2027 (synergy realization + credit normalization off the CECL trough) is asymmetric to the upside if unemployment stays sub-4.5%. The real risk isn't the one the market-forces model flagged (catastrophic credit losses) — it's that Discover integration slips, synergies underdeliver, and the stock dead-money's for 18 months while earning its way into the multiple. I'd wait for a pullback to the $190s rather than chase, but I would not short this and I would not call $147 fair value defensible.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-08-07 00:33:52
Verdict Fairly valued around $222 — the 54x P/E is misleadingly high, but on a normalized earnings lens the recovery is already largely priced in; I’d want sub-$190 for a clear margin of safety.

What jumps out is that the stock is not expensive on banking metrics if you believe 2025 was a one-off earnings trough, but it is very expensive if you take the reported earnings at face value. At $221.63, the market cap is $135.97B against year-end equity of $113.62B, so investors are paying only 1.18x book for a franchise that historically should earn materially more than the 2.2% ROE shown for 2025. That is the key tension. Revenue exploded from $39.11B in 2024 to $53.43B in 2025, then stayed elevated with quarterly revenue running $15.23B-$15.58B over the last three quarters, versus just $10.00B in 2025's first quarter and roughly $10B run-rate in late 2024. Yet that surge in revenue did not translate into annual profit: net income fell from $4.75B to $2.45B, and there was a stunning -$4.28B loss in 2025-06. The raw data says this is not a clean growth story at all; it is an earnings-recovery story masked by top-line expansion.

The more important question is whether the recovery is already visible. I think yes, partially. After the June 2025 blowup, net income rebounded to $3.19B in September, then held at $2.13B and $2.17B in the next two quarters. That means the most recent two-quarter annualized earnings power is roughly $8.6B, and if you include the stronger September quarter, the latest three-quarter run-rate is over $10B. On that basis, the headline 54.6x P/E is close to useless. The stock is trading closer to 13x-16x an earnings power range of about $14B-$10B, which is far less demanding and roughly consistent with a large card/bank hybrid in mid-cycle conditions. Pair that with $27.72B of operating cash flow and $26.14B of free cash flow in 2025, plus $62.09B of cash against only $1.09B of stated debt, and the balance-sheet/cash-flow picture looks much sturdier than the income statement alone implies. I do not buy the “high-growth profitable” classification, but I also think the “catastrophic credit losses by 2027” framing is too dramatic relative to the evidence actually here. The data shows a cyclical hit, not franchise impairment.

That said, I still land on fairly valued to slightly rich because the market is already giving Capital One substantial credit for normalization. A 1.18x price-to-book multiple is not distressed pricing for a lender that just posted 4.6% net margin and 0.37% ROA for the year. The dividend payout ratio of 61.8% also looks high against depressed earnings, which suggests management is signaling confidence in forward earnings, but it leaves less room for error if the recovery stalls. And while recent quarterly profitability has stabilized, the margins in the last two quarters, 13.7% and 14.3%, are better than the 2024 trough but still nowhere near the 2021-2022 earnings power implied by annual net income of $12.39B and $7.36B. In other words, the stock does not look optically expensive versus normalized earnings, but it also is not offering a bargain multiple on proven current returns. At $221, you are paying for a comeback that is underway but not yet fully demonstrated.

The best argument against my caution is simple: if the June 2025 loss was tied to a singular event, then the market is still underestimating earnings power. The quarterly sequence after that loss is compelling, especially with revenue stepping up from a roughly $40B annual base to a $60B+ run-rate. If Capital One can convert even a mid-teens net margin on the current revenue base, annual earnings would move dramatically higher than the $2.45B posted in 2025. In that case, 1.18x book would be cheap, not fair, and the stock could deserve a move well above $250. The thesis evaluation's idea that the market is anchoring to depressed earnings is not crazy. Also, the low debt-to-equity and strong free cash flow provide more resilience than many consumer lenders get credit for, and if the Discover-related strategic upside is real, there is legitimate embedded optionality the plain numbers here do not capture.

What would change my mind is straightforward. If the next two quarters keep revenue above $15B and deliver net income above $2.5B each without another reserve-style shock, then the recovery case hardens and I would move bullish, especially if annualized ROE pushes back toward 8%-10%. Conversely, if revenue stays high but margins slip back toward the 10%-12% area, or if another quarter produces sub-$1.5B earnings despite this bigger revenue base, then the topline strength is low quality and the stock is too expensive above 1.1x book. For now, the market is not irrational, but it is also not leaving much valuation cushion.

Grok Reading
Independent reading · grok-4.5 · generated 2026-08-07 00:34:50
Verdict Fairly valued near $220 on 1.18x book and ~15x run-rate earnings; upside if ROE recovers above 8%, downside if charge-offs re-accelerate

The raw numbers describe a company mid-transformation, not a slow-motion credit collapse. Revenue stepped from a $39B run-rate in 2024 to $53.4B in 2025, with the quarterly print jumping permanently from ~$10B to the mid-$15B range after mid-2025—clearly the Discover combination landing in the numbers. The $4.28B loss in Q2 2025 is the ugly accounting and provision spike that accompanies that deal; strip it out and the subsequent three quarters delivered $3.19B, $2.13B and $2.17B of net income, a ~$8.5–9B annualized run-rate. That is still well below the $12B peak of 2021, but it is triple the depressed $2.45B full-year 2025 print that produces the optically absurd 54.6x P/E. Free cash flow of $26.1B against a $136B enterprise, a fortress balance sheet ($62B cash, $1.1B debt, 0.01x D/E), and a 1.18x P/B on $114B of equity are the more relevant anchors. At current run-rate earnings the forward multiple compresses to roughly 15–16x—ordinary for a scaled consumer lender—while any path back even to a mid-single-digit ROE (let alone the historical 10–15%) makes the present book-value multiple look cheap rather than rich.

The market-forces claim that Capital One is a “deteriorating subprime lender” heading for negative earnings by 2027 sits in open contradiction with $27.7B of operating cash flow and three consecutive post-deal quarters of double-digit net margins. The 20.5% revenue CAGR and 36% recent y/y growth are real; the –29% earnings CAGR is almost entirely the arithmetic of one merger quarter and the industry-wide credit normalization that every card issuer has already booked. Insider sales are present but small and mechanical; they do not override the cash-generation picture.

The strongest counter-argument is straightforward and quantitative. Reported 2025 ROE is 2.2%, net margin 4.6%, and the five-year earnings path has marched steadily downhill from $12.4B to $2.45B. Unemployment at 4.1% has little room to fall and ample room to rise; every historical COF drawdown has been led by charge-off spikes that models systematically under-estimate at the turn. The valuation synthesis fair-value range of $147–159 implies the stock is already 33% too expensive, and the 61.8% payout ratio on trough earnings leaves little cushion if credit costs re-accelerate. A smart skeptic would also note that Discover synergies of $2–3B are still ungained and regulatory or integration failure remains a binary risk. I weigh these factors as real but already largely reflected in the 1.18x book multiple and the collapsed trailing P/E; they justify caution on position size, not a structural short.

Two concrete data points would flip the view: (1) two more quarters in which net charge-off rates continue rising and quarterly NI falls back below $1.5B, proving 2025 was not peak stress; or (2) explicit guidance that Discover cost and revenue synergies will undershoot $1.5B annually, removing the principal upside lever.

Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 5.0; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 5.0
fairly valued · conviction 3/5 · Δ +0.0 vs panel · self: 6.0
GPT gpt-5.4 5.0
fairly valued · conviction 3/5 · Δ +0.0 vs panel · self: 5.0
Grok grok-4.5 5.0
fairly valued · conviction 3/5 · Δ +0.0 vs panel · self: 6.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-08-07 01:03:35
Delvantic - Cairn AI
Quality — wait for a dip 6/10
COF is a solid post-Discover franchise, but at $220 I'm paying ~35% over modeled fair value for synergies that haven't shown up per share yet — wait, don't chase.
The cruxWhether Discover synergies and normalized EPS actually materialize fast enough to grow into the price before the consumer credit cycle turns.
Forensic checks Derived mechanically from COF's filed financials — not from the AI lenses
Liquidity & RunwayFortress Balance Sheet
DilutionHeavy Dilution
Earnings QualityGood Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+5
Solid
edge √Σ 115 · risk √Σ 109 · conf 6/10

Capital One shows the profile of a well-capitalized consumer credit franchise: revenue expanded from $30.4B in 2021 to $53.4B in 2025 (with the 2025 step-up reflecting the Discover deal), operating cash flow is robust with OCF/NI at 4.44x, and reported FCF of $26.1B alongside $62B of liquid cash means near-term survival is not a question for this business. Accruals at -2.2% of assets and the strong OCF/NI ratio suggest reported earnings are backed by cash - the Altman Z of 0.36 flagged as distress is a false positive since Z-scores are not meaningful for banks, whose balance sheets are structurally leveraged by design. The soft spot is per-share value creation. Net income has fallen from $12.39B in 2021 to $2.45B in 2025 while diluted shares jumped from ~410M to 608.7M (roughly 49% dilution in one year, tied to the Discover stock-issued acquisition). Even normalizing for merger noise, that is a very large equity print, and EPS has collapsed across the window. Insider activity is exclusively selling (26 sales, 0 buys), though sizes are routine comp-driven dispositions rather than a red flag. Overall this reads as a competent, cash-rich, systemically important credit franchise in the middle of digesting a transformational acquisition. Integration risk, credit-cycle exposure, and the dilution math keep it from a higher tier, but the underlying business machinery looks intact.

Strengths 4
m70
Massive cash generation
FCF of $26.14B in 2025 and OCF/NI of 4.44x indicate reported earnings are more than fully backed by cash - typical for a well-run lender.
m60
Liquid balance sheet
$62.09B liquid cash, $61.01B net cash - the franchise has ample buffer, though for a bank this is partly funding-side rather than distributable.
m55
Revenue scale and growth
Revenue grew from $30.4B (2021) to $53.4B (2025), with the 2025 jump reflecting the Discover acquisition adding a payments network - a strategically meaningful expansion of the moat.
m40
Clean accruals
Accruals at -2.2% of assets suggest no aggressive earnings management; earnings quality module scores it as good.
Concerns 4
m75
Heavy equity issuance
Diluted shares rose from ~410M to 608.7M in a single year (49% dilution), largely from the Discover stock deal. Per-share value creation depends entirely on synergy delivery.
m65
Collapsing net income
Net income fell from $12.39B (2021) to $2.45B (2025) - reflecting normalization from pandemic-era credit tailwinds, higher provisions, and merger costs, but the trajectory is unmistakably down.
m35
Insider tape one-sided
26 sales, 0 open-market buys over the last 12 months ($15.5M sold). Sizes are modest and consistent with routine comp-driven dispositions, but there is no insider vote of confidence.
m30
Credit cycle exposure
As a consumer credit-card focused lender, earnings quality is inherently cyclical - the falling NI trend may reflect rising charge-offs that could deepen if the consumer weakens.
This is a solid, systemically important consumer credit franchise in the middle of digesting a huge acquisition. The cash generation is real, the balance sheet is well-provisioned, and the strategic logic of owning a payments network is genuine. But I cannot ignore that shares outstanding jumped ~50% in a year while net income has been in a multi-year downtrend - even accounting for the Discover deal and cyclical normalization, per-share value creation has been poor. The Altman Z distress flag is noise for a bank. My honest read: a competent, durable business with real franchise value, but the quality picture is clouded until we see whether Discover synergies actually accrete to per-share earnings and whether credit costs stabilize. Solid, not Strong.
Verify before trusting this (6)
  • Discover acquisition synergy targets and integration milestones in the 10-K
  • Credit card net charge-off and delinquency trends vs. reserves
  • CET1 ratio and regulatory capital position post-merger
  • Whether the 608.7M share count is the run-rate or includes further planned issuance
  • Provision for credit losses trajectory and coverage ratios
  • Segment breakdown of the $53.4B revenue - how much is legacy COF vs. Discover contribution
Valuation / Mispricing
-66
Rich
edge √Σ 20 · risk √Σ 100 · conf 6/10
Price $220 vs deserved ~$150-159, roughly -33% upside - clearly rich, not fair. attractive below $165.00

The price anchor is $220 against a composite FV of $159.09 and a signal-adjusted FV of $146.84, implying the market is paying a 38-50% premium to modeled deserved value. Even granting a Solid quality grade and the strategic logic of the Discover integration, that premium is hard to justify when share count is up ~50% year-over-year and net income per share has been trending down. The anchored-PE method corroborates the composite ($159), so the FV inputs look internally consistent rather than one runaway model - this is not a case of a busted DCF distorting the read.

Cheap signals 1
m20
Quality supports a modest premium to FV
Solid franchise, systemically important, real cash generation and payments-network optionality justify paying above bare FV - but not 35-40% above.
Rich / priced-in 3
m70
33% premium to composite FV
Composite FV $159.09 and signal-adjusted $146.84 vs $220 price - a 38-50% overpayment relative to modeled deserved value, with the anchored-PE cross-checking the composite.
m55
Heavy dilution not yet earning its keep
Share count up ~50% post-Discover while net income per share is in a multi-year downtrend; the price embeds full synergy capture that has not shown up in per-share economics.
m45
Priced for a benign credit cycle
Consumer credit lender trading well above modeled FV at a point where charge-offs normalize and NIM faces deposit-cost pressure - little cushion if either turns.
I like the franchise but I am not paying $220 for it. The FV work lands around $150 and the anchored-PE agrees, so I trust the ~35% gap is real, not a modeling artifact. A solid business earns maybe a 10-15% premium to FV, not 40%. I want this closer to $165 before it is interesting, and I would get aggressive below $150 where the signal-adjusted FV sits.
Verify before trusting this (5)
  • Discover integration cost synergies and revenue synergy timing in next 10-Q/transcript
  • Reported vs adjusted EPS bridge and one-time acquisition charges
  • Net charge-off trajectory and reserve build in card segment
  • Deposit beta and NIM guidance
  • Buyback pace once integration capital is freed
General Sentiment
+35
Tailwind
tail √Σ 76 · head √Σ 40 · conf 6/10

The tape is mildly risk-on (regime +46, VIX 15.2) and COF's beta of 1.02 means it participates cleanly in that lift without being whipped around. More importantly, the active narrative on this name has quietly shifted from 'subprime card lender' to 'diversified digitally-native bank with underwriting edge' - a steady-compounder story of moderate intensity and durability that Wall Street is actively validating (recent 36.6% run vs 20.5% long-term CAGR, coverage framing the stock as still below fair value despite a 102% three-year run). That is a textbook re-rating narrative in motion. Analyst/media tone is constructive: the headline flow is skewed toward 'looks cheap on intrinsic value' rather than 'credit cycle turning.' The Trump-account-closure story is noise - it is a compliance/AML story, not a franchise or regulatory-risk story, and the market has ignored it. Offsetting the tailwind: macro backdrop of a 10y at 4.63% and market PE 27.7 is a low-grade headwind for all equities, and the bear case (credit normalization, NIM compression) is a real overhang that limits how far sentiment can stretch. Net: the pressure is positive but not euphoric - a tailwind, not a mania.

Tailwinds 3
m55
Narrative re-rating in motion
The 'digital-native bank / underwriting moat' story is being actively validated in the price (36.6% recent vs 20.5% long-term CAGR) and echoed in coverage framing the stock as still below intrinsic value despite the run.
m35
Risk-on tape suits a beta-1 financial
Regime score +46, VIX 15.2, and building risk appetite give a beta-1.02 large-cap financial a clean lift; no macro stress is punishing cyclicals right now.
m40
Momentum acting as its own tailwind
A 102% three-year run with recent acceleration attracts trend and quant flows; steady-compounder framing keeps it in institutional buy baskets rather than trader hands.
Headwinds 3
m30
Rates and market PE cap upside
10y at 4.63% and market PE 27.7 create a low-grade valuation ceiling for all rate-sensitive financials; not decisive, but it prevents sentiment from running to euphoria.
m25
Latent credit-cycle bear case
The bear narrative (credit normalization, NIM compression, consumer cycle) is dormant but present; any weak card-loss print would flip tone quickly given the moderate-durability story.
m10
Trump account-closure headlines
Politically charged but reputationally neutral (AML compliance framing); minor distraction, no evidence of price impact.
Net tailwind, but a measured one. This is not a cult stock or a mania - it is a steady-compounder narrative being quietly validated by price action and coverage, on a supportive but not euphoric tape. The 'trading below fair value despite the run' framing is exactly the kind of tone that keeps a re-rating going. The real risk is not sentiment today but a credit print that reawakens the bear case; until that happens, the pressure leans up.
Verify before trusting this (4)
  • Next credit card delinquency and net charge-off prints - the single input that could crack the compounder narrative
  • Whether analyst target revisions continue to trend up after the 102% run or start flattening (a sign the re-rating is done)
  • Any escalation of the Trump-accounts story into a broader political/regulatory narrative
  • 10y yield direction - a move above 4.75-5% would materially pressure the whole bank tape
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
not run

This lens hasn't been run for this ticker yet.

The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
About flat -4.5% v0.6.0 View full prediction →

When we made this prediction on Aug 7, 2026, COF was $220.00. We expect it to be $210.00 by Feb 2027, and we consider it great value under $165.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 7, 2026.

Price when predicted$220.00
Our estimate for Feb 2027$210.00-4.5%
Great value below$165.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for COF. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.562 · 9b2927c4 · 2026-08-22 16:52:06